Protein binding and drug clearance
- PMID: 6705422
- DOI: 10.2165/00003088-198400091-00002
Protein binding and drug clearance
Abstract
Most drugs are given continuously. Clearance, the parameter which relates rate of elimination to drug concentration, is important because it defines the rate of administration required to maintain a plateau drug concentration. Together with the extent of distribution outside of plasma, clearance also determines the speed at which a drug is eliminated from the body. The sensitivity of organ clearance of a drug to changes in binding within blood depends on its unbound clearance. If unbound clearance is low, relative to organ blood flow, the extraction ratio (and clearance) will always be low and dependent on plasma binding. If the extraction ratio is high, elimination becomes perfusion rate-limited and clearance will be relatively insensitive to changes in binding, but oral bioavailability may exhibit dependence on binding if the liver is the major eliminating organ. A full insight into the implications of altered binding on pharmacokinetics requires a sound understanding of the physiology both of the eliminating organs and the distribution of drug within the body. Such information is steadily being acquired.
Similar articles
-
Pharmacokinetics in clinical practice. I. Concepts.JAMA. 1976 Apr 26;235(17):1864-7. JAMA. 1976. PMID: 946488
-
Criticism of pharmacokinetic clearance concepts.Int J Clin Pharmacol Ther Toxicol. 1983 Nov;21(11):563-8. Int J Clin Pharmacol Ther Toxicol. 1983. PMID: 6654532
-
Altered hepatic blood flow and drug disposition.Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005. Clin Pharmacokinet. 1976. PMID: 13954 Review.
-
Commentary: a physiological approach to hepatic drug clearance.Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377. Clin Pharmacol Ther. 1975. PMID: 1164821
-
Biological determinants of altered pharmacokinetics in the elderly.Gerontology. 1982;28 Suppl 1:8-17. doi: 10.1159/000212568. Gerontology. 1982. PMID: 7044905 Review.
Cited by
-
Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):183-189. doi: 10.1007/s13318-016-0378-6. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27677732 Review.
-
Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.Eur J Clin Pharmacol. 1991;40(1):87-93. doi: 10.1007/BF00315145. Eur J Clin Pharmacol. 1991. PMID: 2060552
-
Free drug concentration monitoring in clinical practice. Rationale and current status.Clin Pharmacokinet. 1986 Nov-Dec;11(6):450-69. doi: 10.2165/00003088-198611060-00003. Clin Pharmacokinet. 1986. PMID: 3542337 Review.
-
Clinical pharmacokinetics and pharmacodynamics of repaglinide.Clin Pharmacokinet. 2002;41(7):471-83. doi: 10.2165/00003088-200241070-00002. Clin Pharmacokinet. 2002. PMID: 12083976 Review.
-
Quantitative analysis of drug handling by the kidney using a physiological model of renal drug clearance.Eur J Clin Pharmacol. 1993;44(6):521-4. doi: 10.1007/BF02440851. Eur J Clin Pharmacol. 1993. PMID: 8405005
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical